Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 27, 2026 - 01:03:25
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Hong-Ming Hu: Scaling TCR-T for solid tumors through ImmuXell's partnership with IRO®
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Hong-Ming Hu, Founder and Chief Scientific Officer of ImmuXell Biotech, together with Ori's Founder and Chief Scientific Officer, Farlan Veraitch, to...
Related Episodes
Continue listening to more episodes from Ori Spotlight.
Joe DePinto: Why advanced therapies need a new delivery model
Jan 13, 2026 - 01:04:41
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
Dec 16, 2025 - 00:55:35
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Sep 2, 2025 - 00:40:41
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
Aug 12, 2025 - 01:00:07
Henrik Andersen: How smart planning helps CGT scale further, faster
Jul 15, 2025 - 00:54:20
